- Generic name
- Atorvastatin + Ezetimibe
- Strength
- 10 mg + 10 mg
- Dosage form
- Tablet
- Manufactured by
- The ACME Laboratories Ltd.
Liptor EZ 10 Tablet
About Liptor EZ 10 Tablet
Made by The ACME Laboratories Ltd., Liptor EZ 10 is a tablet whose active ingredient is Atorvastatin + Ezetimibe. The doctor determines if this medicine is suitable based on individual health status and cholesterol levels.
There are 8 brands of Atorvastatin + Ezetimibe listed in Bangladesh.
What is Liptor EZ 10 Tablet?
The tablet Liptor EZ 10 contains Atorvastatin + Ezetimibe and is made by The ACME Laboratories Ltd. It contains atorvastatin and ezetimibe, two active ingredients that work in different ways to lower cholesterol. Atorvastatin reduces cholesterol production in the liver and helps clear LDL cholesterol from the blood. Use it only as your doctor directs.
Uses of Liptor EZ 10
The doctor determines if this medicine is suitable based on individual health status and cholesterol levels. It is prescribed alongside a cholesterol-lowering diet and other lifestyle measures. It is not a standalone treatment; it should be combined with multiple risk factor interventions. Ask your doctor whether it is right for your condition.
How to use Liptor EZ 10
You can take it with or without food, but try to take it at the same time each day. Liptor EZ 10 is taken by mouth. Swallow the tablet with water. It is not for self-administration. The dose and how often you take it are decided by your doctor based on your cholesterol levels and other health factors. The doctor decides the dose and how often Liptor EZ 10 should be taken.
Side effects of Liptor EZ 10
Like all medicines, Liptor EZ 10 can cause side effects, though not everyone experiences them. Some people may experience headache, stomach upset, muscle pain, or tiredness. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.
Safety and precautions
It is contraindicated during pregnancy and breastfeeding. Liptor EZ 10 is not for people with active liver disease, unexplained persistent liver enzyme elevations, or hypersensitivity to any ingredient. Do not take Liptor EZ 10 if you have active liver disease or if you are pregnant or may become pregnant, or if you are breastfeeding. Tell your doctor about all the other medicines you take.
Frequently asked questions
What does Liptor EZ 10 treat?
The doctor determines if this medicine is suitable based on individual health status and cholesterol levels. It is prescribed alongside a cholesterol-lowering diet and other lifestyle measures.
How is Liptor EZ 10 used?
You can take it with or without food, but try to take it at the same time each day. Liptor EZ 10 is taken by mouth.
What are the side effects of Liptor EZ 10?
Like all medicines, Liptor EZ 10 can cause side effects, though not everyone experiences them. Some people may experience headache, stomach upset, muscle pain, or tiredness.
Who should be careful with Liptor EZ 10?
It is contraindicated during pregnancy and breastfeeding. Liptor EZ 10 is not for people with active liver disease, unexplained persistent liver enzyme elevations, or hypersensitivity to any ingredient.
Indications
Primary Hyperlipidemia: This tablet is indicated for the reduction of elevated total cholesterol (total-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and non-high-density lipoprotein cholesterol (non-HDL-C), and to increase high-density lipoprotein cholesterol (HDL-C) in patients with primary (heterozygous familial and non-familial) hyperlipidemia or mixed hyperlipidemia.
Homozygous Familial Hypercholesterolemia (HoFH): This tablet is indicated for the reduction of elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to other lipid lowering treatments (e.g., LDL apheresis) or if such treatments are unavailable.
Pharmacology
Ezetimibe: Ezetimibe reduces blood cholesterol by inhibiting the absorption of cholesterol by the small intestine. The molecular target of ezetimibe has been shown to be the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is involved in the intestinal uptake of cholesterol and phytosterols. In a 2-week clinical study in 18 hypercholesterolemic patients, ezetimibe inhibited intestinal cholesterol absorption by 54%, compared with placebo. Ezetimibe had no clinically meaningful effect on the plasma concentrations of the fat-soluble vitamins A, D, and E and did not impair adrenocortical steroid hormone production. Ezetimibe does not inhibit cholesterol synthesis in the liver or increase bile acid excretion. Ezetimibe localizes at the brush border of the small intestine and inhibits the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver. This causes a reduction of hepatic cholesterol stores and an increase in clearance of cholesterol from the blood; this distinct mechanism is complementary to that of statins.
Dosage & Administration
Interaction
- Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir), gemfibrozil: Avoid this tablet
- HIV protease inhibitor (lopinavir plus ritonavir): Use with caution and lowest dose necessary.
- Clarithromycin, itraconazole, HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir): Do not exceed 10/20 mg this tablet daily.
- HIV protease inhibitor (nelfinavir), hepatitis C protease inhibitor (boceprevir): Do not exceed 10/40 mg this tablet daily.
- Other lipid-lowering medications: Use with fenofibrates or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. Caution should be used when prescribing with this tablet.
- Fenofibrates: Combination increases exposure of ezetimibe. If cholelithiasis is suspected in a patient receiving ezetimibe and a fenofibrate, gallbladder studies are indicated and alternative lipid- lowering therapy should be considered.
- Cholestyramine: Combination decreases exposure of ezetimibe.
- Digoxin: Patients should be monitored appropriately.
- Oral contraceptives: Values for norethindrone and ethinyl estradiol may be increased.
- Rifampin should be simultaneously coadministered with this tablet.
Contraindications
- Active liver disease or unexplained persistent elevations of hepatic transaminase levels.
- Hypersensitivity to any component of this tablet.
- Women who are pregnant or may become pregnant.
- Nursing mothers.
Pregnancy & Lactation
Precautions & Warnings
Skeletal muscle effects (e.g., myopathy and rhabdomyolysis): Risks increase with higher doses and concomitant use of certain CYP3A4 inhibitors, fibric acid derivatives, and cyclosporine. Predisposing factors include advanced age (>65), uncontrolled hypothyroidism, and renal impairment. Rare cases of rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported.
Liver enzyme abnormalities: Persistent elevations in hepatic transaminase can occur. Check liver enzyme tests before initiating therapy and as clinically indicated thereafter.
Storage Conditions
Alternative brands of Atorvastatin + Ezetimibe
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.